Opendata, web and dolomites

BIOTIMA

Market Opportunity Confirmation for Biomimetic Tissue Matrix Products

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BIOTIMA project word cloud

Explore the words cloud of the BIOTIMA project. It provides you a very rough idea of what is the project "BIOTIMA" about.

techniques    reduce    map    versatility    made    demonstrated    alternatives    scaling    regeneration    ferentis    biocompatible    predictive    commercialization    deposited    biosynthetic    bioplastic    piloted    clear    tm    mimicking    analyze    morphology    replication    advantages    artificial    functional    tissue    primary    solution    innovative    customers    cells    roadmap    expensive    elaboration    biomimetic    preparation    scientists    hydrogel    drug    models    cell    cosmetics    market    clinically    organs    fabrication    modified    tools    nanoengineering    composition    experiment    matrix    medicine    employing    optically    functionally    substrates    patent    culture    lack    effort    tissues    inhumane    efficient    regenerative    vitro    closely    biotima    thorough    toxicity    human    physiologically    materials    adopter    standard    reflect    prototypes    native    surface    versatile    confirm    prepare    seeded    patterned    material    variety    lab    industry    nano    free    animal    business    environments    discovery    stable    feasibility    pending    properly    plan   

Project "BIOTIMA" data sheet

The following table provides information about the project.

Coordinator
FERENTIS 

Organization address
address: SAVANORIU 231
city: VILNIUS
postcode: 2300
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Lithuania [LT]
 Project website http://www.ferentis.eu
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-02-01   to  2015-07-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FERENTIS LT (VILNIUS) coordinator 50˙000.00

Map

 Project objective

A variety of in vitro human tissue models are used in the fields of testing of cosmetics products, drug discovery and regenerative medicine. Most models made from artificial materials do not properly reflect the native tissue morphology and cell composition, while those made of seeded cells/tissues of specific organs lack versatility and are expensive to use. Ferentis’ Biomimetic Tissue Matrix (BIOTIMA) project addresses the need for efficient toxicity testing/cell culture tools enabling more physiologically relevant, predictive and functional tissue mimicking models, that should become the EU standard in its effort to reduce expensive and inhumane animal testing. Ferentis scientists have developed an innovative patent-pending biosynthetic material –a bioplastic- that is cell-free, stable, biocompatible and optically clear and has demonstrated clinically to promote regeneration of cells. By employing advanced surface nanoengineering techniques, this biosynthetic hydrogel can be deposited, functionally modified and patterned on different substrates, for a variety of lab tissue experiment applications. The unique advantages of our tissue matrix include unique biomimetic properties, most closely mimicking those of the real tissue, and advanced nano-fabrication methods, allowing a cost efficient, versatile and easy to use solution. The prototypes of our TM cell culture tools have been demonstrated in relevant testing environments and now are being piloted with our early adopter customers, with a primary focus on the cosmetics industry. A thorough feasibility study and an elaboration of a business plan is needed in order to analyze the market, map and confirm commercialization alternatives and prepare the roadmap for scaling-up in preparation for Phase II, market replication.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIOTIMA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIOTIMA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

S3D (2015)

Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.

Read More  

NANOHIGH (2015)

High volume production facility for high accuracy nanocapsules

Read More  

FREE-D (2015)

CNC dynamic mold for producing freely curved glass panels

Read More